StockData
Bioventus Inc. logo

Bioventus Inc. (BVS) stock

BVSNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 27, 2026Last filing: 10-Q on Nov 2, 2026Score 13/3041% below fair value
$10.62+0.02 (+0.19%)

Close on Nov 18, 2026Market cap $893.06MP/E 13.8Yield –

Bioventus shares outstanding

Diluted shares outstanding: the weighted share count used for earnings per share, adjusted for stock splits.

Bioventus's shares outstanding was 71M at Jun 27, 2026. For fiscal 2025 it was 69M, up 6.8% from the year before. The highest annual figure on record is 69M in fiscal 2025.

Annual shares outstanding

PeriodPeriod endValueChange
FY2025Dec 31, 202569M+6.8%
FY2024Dec 31, 202465M+3.0%
FY2023Dec 31, 202363M+2.0%
FY2022Dec 31, 202261M+35.0%
FY2021Dec 31, 202145M–

Quarterly shares outstanding

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 27, 202671M+3.4%
Q1 FY2026Mar 28, 202670M+6.1%
Q4 FY2025Dec 31, 202569M+5.8%
Q3 FY2025Sep 27, 202569M+5.5%
Q2 FY2025Jun 28, 202569M+7.0%
Q1 FY2025Mar 29, 202566M+4.1%
Q4 FY2024Dec 31, 202465M+3.8%
Q3 FY2024Sep 28, 202465M+3.9%
Q2 FY2024Jun 29, 202464M+2.4%
Q1 FY2024Mar 30, 202463M+2.0%
Q4 FY2023Dec 31, 202363M+1.9%
Q3 FY2023Sep 30, 202363M+1.9%
Q2 FY2023Jul 1, 202363M+1.8%
Q1 FY2023Apr 1, 202362M+2.7%
Q4 FY2022Dec 31, 202262M+9.7%
Q3 FY2022Oct 1, 202262M+47.4%
Q2 FY2022Jul 2, 202261M+47.1%
Q1 FY2022Apr 2, 202260M+44.7%
Q4 FY2021Dec 31, 202156M–
Q3 FY2021Oct 2, 202142M–
Q2 FY2021Jul 3, 202142M–
Q1 FY2021Apr 3, 202142M–

More Bioventus figures

See a number that looks wrong?